Article info

Download PDFPDF

Original research
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3

Authors

  1. Correspondence to Professor Daniel Aletaha; daniel.aletaha{at}meduniwien.ac.at
View Full Text

Citation

Aletaha D, Westhovens R, Gaujoux-Viala C, et al
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3

Publication history

  • Received February 6, 2021
  • Accepted July 24, 2021
  • First published August 12, 2021.
Online issue publication 
August 12, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.